Ovarian Cancer
Research from R.L. Prentice et al broadens understanding of ovarian cancer
Published in Women's Health Weekly, January 10th, 2008
According to a study from the United States, "Background The Women's Health Initiative Dietary Modification (DM) Randomized Controlled Trial evaluated the effects of a low-fat dietary pattern on chronic disease incidence, with breast cancer and colorectal cancer as primary outcomes. The trial protocol also listed ovarian cancer and enclometrial cancer as outcomes that may be favorably affected by the intervention."
"Methods A total of 48835 postmenopausal women were randomly assigned during 1993-1998 to a DM intervention (n = 19541) or comparison (usual diet; n = 29294) group and followed up for an average of 8.1 years. The intervention goal was to reduce total fat...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Anthracyclines improve survival in HER2-positive breast cancer patients - Breast Cancer
Bevacizumab found to improve survival for patients with advanced breast cancer - Breast Cancer
Chemotherapy and tamoxifen reduce risk of second breast cancer - Breast Cancer
Ireland Cancer Center researcher finds standard treatment for breast cancer not followed - Breast Cancer
Reconstruction surgery rarely discussed with breast cancer patients - Breast Cancer
Taxol with avastin produces noteworthy results - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
